Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03565445
Brief Title: A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

First Submitted : May 25, 2018
First Submitted that Met QC Criteria : June 20, 2018
First Posted : June 21, 2018

Last Update Submitted that Met QC Criteria : May 26, 2021
Last Update Posted : May 28, 2021